Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMc0909190 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
PNEUMOCOCCAL SEROTYPE DISTRIBUTION AND COVERAGE OF EXISTING AND PIPELINE PNEUMOCOCCAL VACCINES.
medRxiv
December 2024
School of Public Health, University of California, Berkeley, Berkeley, California, United States.
Background: (pneumococcus) causes invasive pneumococcal disease (IPD) and non-invasive acute respiratory infections (ARIs). Three pneumococcal conjugate vaccines (PCVs) are recommended in the United States with additional products in clinical trials. We aimed to estimate 1) proportions of IPD cases and pneumococcal ARIs caused by serotypes targeted by existing and pipeline PCVs and 2) annual U.
View Article and Find Full Text PDFThe Roles of Acculturation and Pre-migration Experiences in Influencing the Confidence of Vietnamese Parents in Vaccine Use Among Adolescents.
J Community Health
December 2024
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N. Lake Shore Dr., Suite 1400, Chicago, IL, 60611, USA.
Vaccine confidence is a critical antecedent of vaccine uptake. Little research has examined vaccine confidence among Asian communities, particularly the associations with acculturation and pre-migration experiences. We explored this issue among U.
View Article and Find Full Text PDFEffects Of E-Cigarette Warning Labels About Mental Health Consequences Of Nicotine Addiction Among Young Adults In The Us: Results From A Randomized Controlled Experiment.
Nicotine Tob Res
December 2024
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Introduction: Since 2016, the U.S. Food and Drug Administration (FDA) has required e-cigarette packaging and advertising to bear the warning: "WARNING: THIS PRODUCT CONTAINS NICOTINE.
View Article and Find Full Text PDFTwo meningococcal serogroup B vaccines are licensed for use in the United States. In August 2024, the Food and Drug Administration (FDA) changed the label for the meningococcal serogroup B MenB-4C vaccine (Bexsero) from a 2-dose schedule (intervals of 0 and ≥1 month) to a 2-dose schedule (0 and 6 months) and added a 3-dose schedule (0, 1-2, and 6 months), based on new immunogenicity data. On October 24, 2024, the Advisory Committee on Immunization Practices (ACIP) voted to update its recommendations for the MenB-4C dosing interval and schedule to align with the new FDA label.
View Article and Find Full Text PDF[Lyme's disease. A critical analysis of its presence in Argentina].
Medicina (B Aires)
December 2024
Departamento de Bacteriología, Servicio Bacteriología Especial, INEI-ANLIS Carlos G. Mabrán, Buenos Aires, Argentina.
Introduction: Lyme disease (LD) is caused by bacteria of the Borrelia burgdorferi sensu lato complex and transmitted by the bite of ticks of the Ixodes ricinus complex. To date, no autochthonous cases have been reported in Argentina. Its diagnosis involves serological tests included in a two-step algorithm.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!